Pentosan polysulfate sodium 100 mg + Placebo + Pentosan polysulfate sodium 100 mg
ApprovedTerminated 0 watching 0 views this week🔥 Hot
85
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Interstitial Cystitis
Conditions
Interstitial Cystitis
Trial Timeline
Sep 1, 2003 → Jun 1, 2011
NCT ID
NCT00086684About Pentosan polysulfate sodium 100 mg + Placebo + Pentosan polysulfate sodium 100 mg
Pentosan polysulfate sodium 100 mg + Placebo + Pentosan polysulfate sodium 100 mg is a approved stage product being developed by Johnson & Johnson for Interstitial Cystitis. The current trial status is terminated. This product is registered under clinical trial identifier NCT00086684. Target conditions include Interstitial Cystitis.
Hype Score Breakdown
Clinical
30
Activity
20
Company
10
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00086684 | Approved | Terminated |
Competing Products
20 competing products in Interstitial Cystitis